What are the major opportunities in the Kesimpta market? What are the strategies for the Kesimpta market?

For detailed insights on the major opportunities and strategies in the Kesimpta market, Read More

How does the Kesimpta market relate to the overall economy and other similar markets?

For detailed insights on Kesimpta's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Kesimpta industry?

For detailed insights on the mergers and acquisitions in the Kesimpta industry, Read More

What are the key dynamics influencing the Kesimpta market growth? SWOT analysis of the Kesimpta market.

For detailed insights on the key dynamics influencing the Kesimpta market growth and SWOT analysis of the Kesimpta industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Kesimpta Global Market Report 2025

Name: Kesimpta Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Treatment Of Rhabdomyosarcoma (RMS), Treatment Of Clinically Isolated Syndrome (CIS), Treatment Of Active Secondary Progressive Multiple Sclerosis (SPMS)), By Formulation (Injectable formulation, Pre-filled Syringes Or Autoinjectors), By Patient Demographics (Pediatric Patients, Adult Patients, Geriatric Patients), By Distribution Channel (Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Specialty Pharmacies, Home Healthcare Providers, Neurology Clinics)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Kesimpta Market?

Kesimpta (ofatumumab) is a prescription medication classified as a monoclonal antibody used to treat relapsing forms of multiple sclerosis (MS) in adults. It works by targeting and depleting B-cells, which play a role in the immune system's attack on the nervous system in multiple sclerosis (MS). Administered as a subcutaneous injection, Kesimpta offers a more convenient option compared to intravenous therapies. Kesimpta is generally well-tolerated, but potential side effects include infections, headache, and injection site reactions.

The main indication types of kesimpta are treatment of rhabdomyosarcoma (RMS), treatment of clinically isolated syndrome (CIS), and treatment of active secondary progressive multiple sclerosis (SPMS). The treatment of rhabdomyosarcoma (RMS), a rare cancer of soft tissue, often involves a combination of surgery, chemotherapy, and radiation therapy to remove or shrink tumors and prevent recurrence. Targeted therapies and clinical trials may be considered for advanced or recurrent cases. The formulations are injectable formulations and pre-filled syringes or autoinjectors, and the patient demographics include pediatric patients, adult patients, and geriatric patients. Various distribution channels are direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and it is used by different end users such as hospitals, specialty pharmacies, home healthcare providers, and neurology clinics.

Kesimpta Market Size and growth rate 2025 to 2029: Graph

What Is The Kesimpta Market Size 2025 And Growth Rate?

The kesimpta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the expansion of healthcare access, advances in biological therapies, increasing prevalence of multiple sclerosis, approval of kesimpta by regulatory authorities, and improving understanding of multiple sclerosis.

What Is The Kesimpta Market Growth Forecast?

The kesimpta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to strong support from healthcare providers, rising demand for subcutaneous injections, growing awareness of multiple sclerosis (MS) and treatment options, increasing prevalence of multiple sclerosis (MS), and approval of new indications. Major trends in the forecast period include advancements in multiple sclerosis (MS) treatment, expansion in emerging markets, a shift towards self-administration, regulatory approvals and expansions, focus on personalized medicine.

Book your 30 minutes free consultation with our research experts

How Is The Kesimpta Market Segmented?

The kesimpta market covered in this report is segmented –

1) By Indication: Treatment Of Rhabdomyosarcoma (RMS), Treatment Of Clinically Isolated Syndrome (CIS), Treatment Of Active Secondary Progressive Multiple Sclerosis (SPMS)

2) By Formulation: Injectable formulation, Pre-filled Syringes Or Autoinjectors

3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Neurology Clinics

What Is Driving The Kesimpta Market? Impact Of Increasing Multiple Sclerosis Prevalence On The Growth Of The Kesimpta Market

The increasing prevalence of multiple sclerosis (MS) is expected to elevate the growth of the kesimpta market going forward. Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, leading to the degeneration of nerve fibers and causing symptoms such as muscle weakness, vision problems, and cognitive impairment. The increasing prevalence of multiple sclerosis (MS) can be attributed to several factors, including improved diagnostics, heightened awareness, and better reporting systems. Kesimpta is used to treat relapsing forms of multiple sclerosis (MS) by targeting B-cells to reduce relapses and slow disability progression. For instance, in July 2023, according to the data from Public Health Scotland, a Scotland-based national organization, in 2022, newly diagnosed patients with multiple sclerosis (MS) increased to 87.2%, up from 85.7%, with 491 new cases reported, bringing the total to 6,359 in 2022. Therefore, the increasing prevalence of multiple sclerosis (MS) is driving the growth of the kesimpta market.

What Is Driving The Kesimpta Market? Impact Of Rising Healthcare Expenditure On The Market Growth

The rise in healthcare expenditure is expected to accelerate the growth of the kesimpta market going forward. Healthcare expenditure refers to the total spending on healthcare services, including hospital care, medical research, pharmaceuticals, public health programs, and other related services. The rise in healthcare expenditure is driven by several factors, including an aging population, increased prevalence of chronic diseases, advancements in medical technology, and rising treatment costs. Healthcare expenditure for Kesimpta focuses on improving patient outcomes by reducing relapses and progression of the disease. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the rise in healthcare expenditure drives the growth of the kesimpta market.

Who Are The Major Players In The Global Kesimpta Market?

Major companies operating in the kesimpta market include Novartis AG

What Are The Key Trends Of The Global Kesimpta Market? Kesimpta's Impact On Relapsing Multiple Sclerosis (RMS)

The key trend in the kesimpta market is self-administered, targeted B-cell therapy for the treatment of relapsing forms of multiple sclerosis (RMS). Kesimpta's self-administered, targeted B-cell therapy provides an effective and convenient treatment option for relapsing forms of multiple sclerosis (RMS), reducing relapses and slowing disease progression. For instance, in April 2024, Novartis AG, a Switzerland-based pharmaceutical company, recently released six-year efficacy data for its multiple sclerosis treatment, Kesimpta (ofatumumab), highlighting significant benefits for recently diagnosed, treatment-naïve individuals with relapsing multiple sclerosis (RMS). This data comes from the ALITHIOS open-label extension study, which underscores the importance of early intervention in managing this chronic condition.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Kesimpta Market

North America was the largest region in the kesimpta market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kesimpta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the kesimpta market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Kesimpta Market?

The kesimpta market consists of sales of prefilled syringes, injection forms, and liquid solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Kesimpta Industry?

The kesimpta market research report is one of a series of new reports from The Business Research Company that provides kesimpta market statistics, including kesimpta industry global market size, regional shares, competitors with a kesimpta market share, detailed kesimpta market segments, market trends and opportunities, and any further data you may need to thrive in the kesimpta industry. This kesimpta market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Kesimpta Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Indication: Treatment Of Rhabdomyosarcoma (RMS), Treatment Of Clinically Isolated Syndrome (CIS), Treatment Of Active Secondary Progressive Multiple Sclerosis (SPMS) 2) By Formulation: Injectable formulation, Pre-filled Syringes Or Autoinjectors 3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients 4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies 5) By End User: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Neurology Clinics
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Novartis AG
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Kesimpta Market Characteristics

3. Kesimpta Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Kesimpta Market Trends And Strategies

5. Kesimpta Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Kesimpta Growth Analysis And Strategic Analysis Framework

6.1. Global Kesimpta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Kesimpta Market Growth Rate Analysis

6.4. Global Kesimpta Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Kesimpta Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Kesimpta Total Addressable Market (TAM)

7. Global Kesimpta Pricing Analysis & Forecasts

8. Kesimpta Market Segmentation

8.1. Global Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Treatment Of Rhabdomyosarcoma (RMS)

Treatment Of Clinically Isolated Syndrome (CIS)

Treatment Of Active Secondary Progressive Multiple Sclerosis (SPMS)

8.2. Global Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Injectable formulation

Pre-filled Syringes Or Autoinjectors

8.3. Global Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric Patients

Adult Patients

Geriatric Patients

8.4. Global Kesimpta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Direct Sales

Wholesalers And Distributors

Retail Pharmacies

Online Pharmacies

8.5. Global Kesimpta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Specialty Pharmacies

Home Healthcare Providers

Neurology Clinics

9. Global Kesimpta Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Kesimpta Market Regional And Country Analysis

10.1. Global Kesimpta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Kesimpta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Kesimpta Market

11.1. Asia-Pacific Kesimpta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Kesimpta Market

12.1. China Kesimpta Market Overview

12.2. China Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Kesimpta Market

13.1. India Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Kesimpta Market

14.1. Japan Kesimpta Market Overview

14.2. Japan Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Kesimpta Market

15.1. Australia Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Kesimpta Market

16.1. South Korea Kesimpta Market Overview

16.2. South Korea Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Kesimpta Market

17.1. Western Europe Kesimpta Market Overview

17.2. Western Europe Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Kesimpta Market

18.1. UK Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Kesimpta Market

19.1. Germany Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Kesimpta Market

20.1. France Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Kesimpta Market

21.1. Eastern Europe Kesimpta Market Overview

21.2. Eastern Europe Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Kesimpta Market

22.1. North America Kesimpta Market Overview

22.2. North America Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Kesimpta Market

23.1. USA Kesimpta Market Overview

23.2. USA Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Kesimpta Market

24.1. Canada Kesimpta Market Overview

24.2. Canada Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Kesimpta Market

25.1. South America Kesimpta Market Overview

25.2. South America Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Kesimpta Market

26.1. Middle East Kesimpta Market Overview

26.2. Middle East Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Kesimpta Market

27.1. Africa Kesimpta Market Overview

27.2. Africa Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Kesimpta Market Competitive Landscape And Company Profiles

28.1. Kesimpta Market Competitive Landscape

28.2. Kesimpta Market Company Profiles

28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

29. Global Kesimpta Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Kesimpta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Kesimpta Market

32. Recent Developments In The Kesimpta Market

33. Kesimpta Market High Potential Countries, Segments and Strategies

33.1 Kesimpta Market In 2029 - Countries Offering Most New Opportunities

33.2 Kesimpta Market In 2029 - Segments Offering Most New Opportunities

33.3 Kesimpta Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Kesimpta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Kesimpta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Kesimpta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Global Kesimpta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: Asia-Pacific, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: China, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: India, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Japan, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: Australia, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: South Korea, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: Western Europe, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: UK, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: Germany, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: France, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: Eastern Europe, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: North America, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: USA, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: Canada, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: South America, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Middle East, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Africa, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 61: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Kesimpta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Kesimpta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Kesimpta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Global Kesimpta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: Asia-Pacific, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: China, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: India, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Japan, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: Australia, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: South Korea, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: Western Europe, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: UK, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: Germany, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: France, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: Eastern Europe, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: North America, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: USA, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: Canada, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: South America, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Middle East, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Kesimpta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Kesimpta Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Africa, Kesimpta Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 61: Novartis AG Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Canc...

Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, R...

Frequently Asked Questions

What is the definition of the Kesimpta market?

How will the Kesimpta market drivers and restraints affect the market dynamics? What forces will shape the Kesimpta industry going forward?

The Kesimpta market major growth driver - Impact Of Increasing Multiple Sclerosis Prevalence On The Growth Of The Kesimpta Market. For further insights on the Kesimpta market, request a sample here

What is the forecast market size or the forecast market value of the Kesimpta market?

The Kesimpta market size has grown strongly in recent years. The kesimpta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the expansion of healthcare access, advances in biological therapies, increasing prevalence of multiple sclerosis, approval of kesimpta by regulatory authorities, and improving understanding of multiple sclerosis. The kesimpta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to strong support from healthcare providers, rising demand for subcutaneous injections, growing awareness of multiple sclerosis (MS) and treatment options, increasing prevalence of multiple sclerosis (MS), and approval of new indications. Major trends in the forecast period include advancements in multiple sclerosis (MS) treatment, expansion in emerging markets, a shift towards self-administration, regulatory approvals and expansions, focus on personalized medicine. For further insights on the Kesimpta market, request a sample here

How is the Kesimpta market segmented?

The kesimpta market covered in this report is segmented –
1) By Indication: Treatment Of Rhabdomyosarcoma (RMS), Treatment Of Clinically Isolated Syndrome (CIS), Treatment Of Active Secondary Progressive Multiple Sclerosis (SPMS)
2) By Formulation: Injectable formulation, Pre-filled Syringes Or Autoinjectors
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Neurology Clinics For further insights on the Kesimpta market, request a sample here

Which region has the largest share of the Kesimpta market? What are the other regions covered in the report?

Who are the major players in the Kesimpta market?

Major companies operating in the kesimpta market include Novartis AG . For further insights on the Kesimpta market, request a sample here.

What are the key trends in the Kesimpta market?

Major trends in the Kesimpta market include Kesimpta's Impact On Relapsing Multiple Sclerosis (RMS). For further insights on the Kesimpta market, request a sample here.